Bank of America's CEO said the company spends more than $250 million a year on GLP-1 drugs for employees, calling the growing ...

As Americans are encouraged to go direct with weight-loss drug prescriptions, retail pharmacy chains are poised to win big.

Publix, CVS, Walmart and Walgreens now offer Medicare's GLP-1 Bridge program for eligible patients. Here's who's eligible and ...

CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending ...

Bank of America spends $250M+ yearly on GLP-1 weight-loss drugs, now 13% of healthcare spend. Learn why it’s a “good ...

The agreement involves Indiana-based drug manufacturer Eli Lilly.

A new survey finds nearly half of GLP-1 users would pause retirement savings or take on debt before quitting Wegovy or Zepbound. Full findings inside.

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars ...

About 11% of Americans are on GLP-1 weight-loss drugs, according to Gallup. With changed bodies, many are inclined to try on ...

Found connects patients with licensed clinicians, personalized weight loss plans and GLP-1 treatments. Here's how to save ...

The rising demand for GLP-1 medications like Ozempic and Wegovy, which can cost thousands of dollars per patient each year, ...

Bank of America Corp BAC allocates millions each year to provide GLP-1 obesity medications for employees, with CEO Brian Moynihan calling it an investment in workforce health and productivity. "We ...